CG
ADMA icon

Caprock Group’s ADMA Biologics ADMA Stock Holding History

Caprock Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,598
Closed -$212K – 998
2024
Q3 		$212K Sell
10,598
-3,505
-25% -$54.5K 0.01% 828
2024
Q2 		$158K Buy
14,103
+423
+3% +$3.55K 0.01% 813
2024
Q1 		$90.3K Buy
13,680
+1,452
+12% +$7.94K 0.01% 701
2023
Q4 		$55.3K Sell
12,228
-89
-0.7% -$329 ﹤0.01% 685
2023
Q3 		$44.1K Buy
12,317
+2,056
+20% +$7.91K ﹤0.01% 651
2023
Q2 		$37.9K Buy
+10,261
New +$38K ﹤0.01% 651

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Caprock Group's ADMA Position: Q4 2024 in Review

Caprock Group sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 10,598 shares — an estimated $212K sold.

Caprock Group first reported a position in ADMA in Q2 2023 and held it in 6 quarters. The position peaked at $212K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

  • Caprock Group reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
  • Caprock Group sold 10,598 ADMA Biologics shares in Q4 2024, an estimated $212K.
  • Caprock Group first reported a position in ADMA Biologics in Q2 2023 and held it in 6 quarters.
  • Caprock Group's ADMA Biologics position peaked at $212K in Q3 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Caprock Group's 13F filing for Q4 2024, filed 23 Jan 2025.